Vidasym Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $42K
Latest Deal Amount
  • Investors
  • 3

Vidasym General Information


Developer of treatment for chronic kidney disease. The company has two clinical stage drugs for treatment of Chronic Kidney Disease: a vitamin D receptor modulator and a phosphate binder.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2201 West Campbell Park Drive
  • Suite 13
  • Chicago, IL 60612
  • United States
+1 (847) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidasym Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 11-May-2015 $42K 00.00 Completed Generating Revenue
4. Grant 31-Aug-2014 00000 00.00 Completed Generating Revenue
3. Grant 31-Aug-2013 00000 00.00 Completed Startup
2. Angel (individual) $2.5M $2.5M Completed Startup
1. Angel (individual) Completed Startup
To view Vidasym’s complete valuation and funding history, request access »

Vidasym Executive Team (2)

Name Title Board Seat Contact Info
Ruth Wu-Wong Ph.D Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Vidasym Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Alan Lau Angel (individual) Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Vidasym’s complete investors history, request access »